July 3rd 2025
A look back at the most important FDA approvals, clinical research, and expert perspectives shaping ob-gyn care in the first half of 2025.
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment
View More
Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer
View More
Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer
View More
Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer
View More
Labor neuraxial analgesia and maternal morbidity
April 21st 2022The use of labor neuraxial analgesia for vaginal delivery was associated with a 14% decrease in the risk of severe maternal morbidity (SMM), including postpartum hemorrhage (PPH), compared to vaginal delivery without neuraxial analgesia, according to a study published in JAMA Network Open.
Read More
SARS-CoV-2 infections and serious obstetric complications
April 20th 2022A retrospective cohort study published in JAMA found that pregnant and postpartum women with SARS-CoV-2 infection were at a significantly increased risk of maternal mortality or serious morbidity from common obstetric complications.
Read More
SMFM Consult Series #60: Management of pregnancies resulting from IVF
This Consult discusses the management of pregnancies achieved with in vitro fertilization and provides recommendations based on the available evidence.
Read More
Fetal exposure to marijuana linked to increased fat mass, glucose levels in early life
March 31st 2022An analysis of more than 100 mother-child pairs from Colorado found children with fetal exposure to cannabis had increased fat mass and fasting glucose levels compared to their counterparts without fetal exposure to cannabis.
Read More
This Consult has been endorsed by the American College of Obstetricians and Gynecologists (ACOG) and replaces the Society for Maternal-Fetal Medicine's (SMFM) Statement #4, Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery, August 2016.
Read More
History of spontaneous abortion linked to increased risk of gestational diabetes
March 8th 2022An analysis of data from more than 100k pregnant women suggests a history of spontaneous abortion was associated with an 18% increase in risk of subsequent gestational diabetes, with a history of multiple spontaneous abortions associated with an even greater risk.
Read More
Impact of dual burden differs by insurance type
February 18th 2022Risk factors for the dual burden of severe maternal morbidity and preterm birth differ significantly by insurance type across sociodemographic and perinatal considerations in the state of California, according to a study in the Maternal and Children Health Journal.
Read More
A digital decision aid for shared decision-making in prenatal counseling
February 10th 2022Because the treatment options for imminent extreme premature labor center largely on patient preference, decision aids (DA) can help facilitate the patient-provider discussion and guide the shared decision-making process.
Read More
ICD-10-CM Diagnosis Codes for 2022
February 8th 2022Effective each year on October 1, additions, deletions, and updates to the ICD-10-CM code set are published. This year, no significant changes were made to Chapter 15, the obstetrics chapter. However, there are a few new codes that could affect the practice of maternal-fetal medicine.
Read More
Marijuana exposure during pregnancy may increase adverse birth outcomes
February 8th 2022A review and meta-analysis in JAMA Network Open revealed women exposed to marijuana in pregnancy were at significantly increased risk for adverse neonatal outcomes, including low birth weight, small for gestational age, and preterm delivery.
Read More
Supporting transgender and gender-expansive individuals in reproductive health care
February 4th 2022At the Society for Maternal-Fetal Medicine’s 42nd Annual Meeting, a roundtable discussion explored ways to promote inclusivity and support transgender and gender-expansive individuals in the women’s health space.
Read More
Protocols for High-Risk Pregnancies, 7th Edition Prenatal testing for chromosomal abnormalities
February 3rd 2022Protocol 5 - In this protocol, Norton reviews the pathophysiology of fetal aneuploidy and the wide range of tests for it. Included are perspectives on cell-free DNA testing, first-trimester combined screening, nuchal translucency (NT) sonography, and pregnancy-associated plasma protein A (PAPP-A) and human chorionic gonadotropin (hCG), as well as quad marker screening in the second trimester in appropriate cases, and combined first- and second-trimester screening.
Read More
The effect of eating disorders in pregnancy on neurodevelopmental risk in infants
January 24th 2022Eating disorders carry many risks. An investigation looks into whether they can increase the risk of certain neurodevelopmental conditions in the children of mothers with a history of eating disorders.
Read More